Your browser doesn't support javascript.
loading
Fibrinolysis inhibitors in plaque stability: a morphological association of PAI-1 and TAFI in advanced carotid plaque.
Jönsson Rylander, A-C; Lindgren, A; Deinum, J; Bergström, G M L; Böttcher, G; Kalies, I; Wåhlander, K.
Affiliation
  • Jönsson Rylander AC; CVMD IMED AstraZeneca R&D Mölndal, Mölndal, Sweden.
  • Lindgren A; Personalised Healthcare and Biomarkers, AstraZeneca R&D Mölndal, Mölndal, Sweden.
  • Deinum J; CVMD IMED AstraZeneca R&D Mölndal, Mölndal, Sweden.
  • Bergström GM; Sahlgrenska Center for Cardiovascular and Metabolic Research, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
  • Böttcher G; CSM Pathology Sciences, AstraZeneca R&D Mölndal, Sweden.
  • Kalies I; CVMD GMed, AstraZeneca R&D Mölndal, Sweden.
  • Wåhlander K; CVMD Translational Medicine Unit, Early Clinical Development, AstraZeneca R&D Mölndal, Mölndal, Sweden.
J Thromb Haemost ; 15(4): 758-769, 2017 04.
Article in En | MEDLINE | ID: mdl-28135035
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carotid Stenosis / Plasminogen Activator Inhibitor 1 / Carboxypeptidase B2 / Fibrinolysis Type of study: Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2017 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carotid Stenosis / Plasminogen Activator Inhibitor 1 / Carboxypeptidase B2 / Fibrinolysis Type of study: Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2017 Document type: Article Affiliation country: Country of publication: